Transferability of Model-Based Economic Evaluations: The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands

Brigitte A. B. Essers*, Shanley C. Seferina, Vivianne C. G. Tjan-Heijnen, Johan L. Severens, Annoesjka Novak, Marjolein Pompen, Ulrich H. Oron, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)375-380
JournalValue in Health
Issue number4
Publication statusPublished - 2010


  • HER2-positive breast cancer
  • model-based economic evaluation
  • transferability
  • trastuzumab

Cite this